US company 22nd Century is already demonstrating its commitment to continue expanding its intellectual property (IP) in the area of reduced-nicotine tobacco, which it said it would undertake during a presentation of its third quarter financial results.
The biotechnology company has announced an additional reduced-nicotine-content technology licence with North Carolina State University – one of several licence and development activities the firm says are in progress.